International Journal of Retina and Vitreous is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE).
IJRV receives first Impact Factor
We would like to announce with great pleasure that IJRV’s first 2022 Impact Factor has now been released, and it’s 2.3.
This is great news for the journal, since all expected indexing goals have now been achieved.
We would like to thank our prior Editors-in-Chief, Eduardo B. Rodrigues and Jay Duker, as well as the Brazilian Retina and Vitreous Society, alongside all members of the editorial board, reviewers and authors who have trusted in the journal's reputation.
Gustavo B Melo and Marcelo Casella, Editors-in-Chief
The Digital Age in Retinal Practice
Guest Editors:
Lorenzo Ferro Desideri: The University Hospital of Ophthalmology, Inselspital, Switzerland
Rodrigo Anguita: The University Hospital of Ophthalmology, Inselspital, Switzerland
Daniel Lavinsky: Federal University of Rio Grande do Sul, Brazil
Submission Status: Open
Articles
-
-
Clinical trial to test the safety of the EVA Nexus surgical platform
-
Effect of internal limiting membrane surgical techniques on the idiopathic and refractory management of macular holes: a systematic review and meta-analysis
-
Image quality comparison of AirDoc portable retina camera versus eyer in a diabetic retinopathy screening program
-
Analysis of optical coherence tomography biomarker probability detection in central serous chorioretinopathy by using an artificial intelligence-based biomarker detector
-
A review of optical coherence tomography angiography (OCTA)
-
Clinical applications of fundus autofluorescence in retinal disease
-
Low dose corticosteroid in association with methotrexate for therapy of ocular sarcoidosis: report of a case
-
Timing and outcomes after silicone oil removal in proliferative vitreoretinopathy: a retrospective clinical series
-
Optic disc pit maculopathy: when and how to treat? A review of the pathogenesis and treatment options
Code of Conduct
Featured articles
[review] Pipeline therapies for neovascular age related macular degeneration
[clinical trial] Safety and efficacy of Razumab™ in wet age-related macular degeneration: a post-marketing, prospective ASSET study
[case report] Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
Indexing
The journal is indexed in Web of Science (Core Collection) Scopus, PubMed, PubMed Central, and DOAJ (Directory of Open Access Journals).
Aims and scope
International Journal of Retina and Vitreous focuses on the ophthalmic subspecialty of vitreoretinal disorders. The journal presents original articles on new approaches to diagnosis, outcomes of clinical trials, innovations in pharmacological therapy and surgical techniques, as well as basic science advances that impact clinical practice. Topical areas include, but are not limited to:
- Imaging of the retina, choroid and vitreous
- Innovations in optical coherence tomography (OCT)
- Small-gauge vitrectomy, retinal detachment, chromovitrectomy
- Electroretinography (ERG), microperimetry, other functional tests
- Intraocular tumors
- Retinal pharmacotherapy & drug delivery
- Diabetic retinopathy & other vascular diseases
- Age-related macular degeneration (AMD) & other macular entities
Wide-field Imaging in Retina and Vitreous Diseases
This supplement brings together up-to-date, open access reviews on the application of wide-field imaging in a number of retinal pathologies, such as diabetic retinopathy, hereditary retinal degeneration and retinal vein occlusions.
Sign up to receive article alerts
International Journal of Retina and Vitreous is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
The official journal of the Brazilian Retina and Vitreous Society
International Journal of Retina and Vitreous is endorsed by the Pan American Society of Retina and Vitreous
Annual Journal Metrics
-
2022 Citation Impact
2.3 - 2-year Impact Factor
1.011 - SNIP (Source Normalized Impact per Paper)
0.639 - SJR (SCImago Journal Rank)2023 Speed
10 days submission to first editorial decision for all manuscripts (Median)
43 days submission to accept (Median)2023 Usage
548,806 downloads
137 Altmetric mentions